- Home
- CRBU vs EVM Comparison
CRBU vs EVM Comparison
Compare CRBU & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- EVM
- Stock Information
- Founded
- CRBU 2011
- EVM 2002
- Country
- CRBU United States
- EVM United States
- Employees
- CRBU N/A
- EVM N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- EVM Finance/Investors Services
- Sector
- CRBU Health Care
- EVM Finance
- Exchange
- CRBU Nasdaq
- EVM Nasdaq
- Market Cap
- CRBU 236.3M
- EVM 227.2M
- IPO Year
- CRBU 2021
- EVM N/A
- Fundamental
- Price
- CRBU $1.79
- EVM $9.20
- Analyst Decision
- CRBU Strong Buy
- EVM
- Analyst Count
- CRBU 4
- EVM 0
- Target Price
- CRBU $12.00
- EVM N/A
- AVG Volume (30 Days)
- CRBU 1.5M
- EVM 55.8K
- Earning Date
- CRBU 11-06-2024
- EVM 01-01-0001
- Dividend Yield
- CRBU N/A
- EVM 4.01%
- EPS Growth
- CRBU N/A
- EVM N/A
- EPS
- CRBU N/A
- EVM 0.20
- Revenue
- CRBU $11,475,000.00
- EVM N/A
- Revenue This Year
- CRBU N/A
- EVM N/A
- Revenue Next Year
- CRBU N/A
- EVM N/A
- P/E Ratio
- CRBU N/A
- EVM $47.61
- Revenue Growth
- CRBU N/A
- EVM N/A
- 52 Week Low
- CRBU $1.50
- EVM $7.67
- 52 Week High
- CRBU $8.33
- EVM $9.59
- Technical
- Relative Strength Index (RSI)
- CRBU 37.96
- EVM 35.42
- Support Level
- CRBU $1.72
- EVM $9.20
- Resistance Level
- CRBU $1.97
- EVM $9.67
- Average True Range (ATR)
- CRBU 0.14
- EVM 0.08
- MACD
- CRBU -0.03
- EVM -0.04
- Stochastic Oscillator
- CRBU 9.12
- EVM 7.45
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income, and alternative strategies to institutional investors, both in the United States and internationally.